Advanced Pharmaceutical Solutions in Cardiology
Results of several major trials has been released on the past recent years to significantly reduce major cardiovascular events with an extraordinary impact in both pharmacological cardiologist’s therapeutic arsenal and public health economics.
FOURIER, CANTOS, COMPASS, PARADIGM-HF… are some of them and we will review how these landmark trials has changed the way cardiomyopathy
patients are and will be treated today and in an early future.
KEYWORDS & TOPICS
Ischemic Cardiomyopathy, Diabetes and Cardiomyopathy, Adverse or
Cardiovascular Events and LDL-C, Secondary CV Prevention, Inflammatory
Title: 2018: State of the art in Cardiology Pharmaceutical Solutions
Speaker: Luis Rodríquez Padial
Institution: Complejo Hospitalario de Toledo, Spain.
Title: Reduced major cardiovascular events by using IPCSK9. Outcomes from the
Speaker: TBD On behalf of the FOURIER Steering Committee
Name: Ignacio Fernández Lozano
Institution: Hospital Puerta de Hierro, Madrid, Spain